These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1707115)

  • 1. Arguments supporting the use of calcium antagonists in idiopathic dilated cardiomyopathy: theoretical considerations and clinical results.
    Figulla HR; Kreuzer H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S45-9. PubMed ID: 1707115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beneficial long-term effects of diltiazem on the course of dilated cardiomyopathy].
    Figulla HR; von Rechenberg J; Wiegand V; Soballa R; Kreuzer H
    Z Kardiol; 1989; 78 Suppl 5():36-42. PubMed ID: 2517156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial.
    Figulla HR; Gietzen F; Zeymer U; Raiber M; Hegselmann J; Soballa R; Hilgers R
    Circulation; 1996 Aug; 94(3):346-52. PubMed ID: 8759075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of long-term diltiazem treatment in dilated cardiomyopathy.
    Figulla HR; Rechenberg JV; Wiegand V; Soballa R; Kreuzer H
    J Am Coll Cardiol; 1989 Mar; 13(3):653-8. PubMed ID: 2918172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolving role of calcium channel blockers in heart failure.
    Pieper JA
    Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine].
    Klein W; Brandt D; Fluch N; Maurer E
    Z Kardiol; 1982 Jun; 71(6):398-405. PubMed ID: 6812301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists in congestive heart failure].
    Barbieri L; Mestroni L; Camerini F
    G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis and therapy of dilated cardiomyopathy. Possible indications for calcium antagonists].
    Figulla HR
    Fortschr Med; 1989 May; 107(16):370. PubMed ID: 2661381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G
    Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cardiomyopathy using Ca blockers].
    Matsumori A; Tominaga M; Kawai C
    Nihon Rinsho; 1989 Aug; 47(8):1825-30. PubMed ID: 2585747
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
    Suwa M; Ito T; Otake Y; Moriguchi A; Hirota Y; Kawamura K
    Jpn Circ J; 1996 Oct; 60(10):767-73. PubMed ID: 8933239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.